Breast mass
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria of benign breast tumor, breast fibrocystic hyperplasia, breast adenosis, breast fibrocystic breast disease; 2. Women aged 18-70 years old (including 18 and 70 years old); 3. Patients with indications for vac uum-assisted breast biopsy (VABB); 4. Preoperative Hospital Anxiety and Depression Scale (HADS) showed that the patient had anxiety and depression, that is, SAS score =7 points; 5. Patients who volunteered to participate in the trial with the consent of their family members and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Pregnant (preparing for pregnancy) or lactating women; 2. Concomitant diseases requiring sex hormone therapy, such as dysfunctional uterine bleeding, amenorrhea, polycystic ovary syndrome, menopausal syndrome, hyperprolactinemia, etc. 3. Patients with malignant tumors; 4.Patients with breast inflammatory disease; 5. Those who are allergic to the ingredients of the trial drugs; 6. Serious primary diseases of the heart, brain, lung, kidney, liver and hematopoietic system; 7. Patients with mental illness or intellectual disability, hearing or cognitive impairment; 8. Patients who have received or are prepared to receive other forms of treatment for anxiety.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart rate variability, blood pressure;Hospital Anxiety and Depression Scale (HADS) score;Preoperative knowledge awareness level; | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraoperative pain VAS scale;Intraoperative cooperation; | — |
Countries
China
Contacts
Guangzhou Women and Children's Medical Center